United States Asthma Drugs Market Report 2017

December 2017 | 102 pages | ID: U0945AFC544EN
QYResearch

Abstracts

In this report, the United States Asthma Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:

• The West
• Southwest
• The Middle Atlantic
• New England
• The South
• The Midwest
• with sales (volume), revenue (value), market share and growth rate of Asthma Drugs in these regions, from 2012 to 2022 (forecast).

United States Asthma Drugs market competition by top manufacturers/players, with Asthma Drugs sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

• GlaxoSmithKline
• Sanofi
• Roche & Novartis
• Teva
• Merck
• AstraZeneca
• Boehringer Ingelheim

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• Long-term Control Medications
• Quick-relief Medications (Rescue Medications)
• Medications for Allergy-induced Asthma

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

United States Asthma Drugs Market Report 2017

1 ASTHMA DRUGS OVERVIEW

1.1 Product Overview and Scope of Asthma Drugs
1.2 Classification of Asthma Drugs by Product Category
  1.2.1 United States Asthma Drugs Market Size (Sales Volume) Comparison by Type (2012-2022)
  1.2.2 United States Asthma Drugs Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
  1.2.3 Long-term Control Medications
  1.2.4 Quick-relief Medications (Rescue Medications)
  1.2.5 Medications for Allergy-induced Asthma
1.3 United States Asthma Drugs Market by Application/End Users
  1.3.1 United States Asthma Drugs Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
  1.3.2 Hospital Pharmacy
  1.3.3 Retail Pharmacy
  1.3.4 Online Pharmacy
1.4 United States Asthma Drugs Market by Region
  1.4.1 United States Asthma Drugs Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 The West Asthma Drugs Status and Prospect (2012-2022)
  1.4.3 Southwest Asthma Drugs Status and Prospect (2012-2022)
  1.4.4 The Middle Atlantic Asthma Drugs Status and Prospect (2012-2022)
  1.4.5 New England Asthma Drugs Status and Prospect (2012-2022)
  1.4.6 The South Asthma Drugs Status and Prospect (2012-2022)
  1.4.7 The Midwest Asthma Drugs Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Asthma Drugs (2012-2022)
  1.5.1 United States Asthma Drugs Sales and Growth Rate (2012-2022)
  1.5.2 United States Asthma Drugs Revenue and Growth Rate (2012-2022)

2 UNITED STATES ASTHMA DRUGS MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Asthma Drugs Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Asthma Drugs Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Asthma Drugs Average Price by Players/Suppliers (2012-2017)
2.4 United States Asthma Drugs Market Competitive Situation and Trends
  2.4.1 United States Asthma Drugs Market Concentration Rate
  2.4.2 United States Asthma Drugs Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Asthma Drugs Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES ASTHMA DRUGS SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2012-2017)

3.1 United States Asthma Drugs Sales and Market Share by Region (2012-2017)
3.2 United States Asthma Drugs Revenue and Market Share by Region (2012-2017)
3.3 United States Asthma Drugs Price by Region (2012-2017)

4 UNITED STATES ASTHMA DRUGS SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2012-2017)

4.1 United States Asthma Drugs Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Asthma Drugs Revenue and Market Share by Type (2012-2017)
4.3 United States Asthma Drugs Price by Type (2012-2017)
4.4 United States Asthma Drugs Sales Growth Rate by Type (2012-2017)

5 UNITED STATES ASTHMA DRUGS SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Asthma Drugs Sales and Market Share by Application (2012-2017)
5.2 United States Asthma Drugs Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES ASTHMA DRUGS PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 GlaxoSmithKline
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Asthma Drugs Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 GlaxoSmithKline Asthma Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Sanofi
  6.2.2 Asthma Drugs Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Sanofi Asthma Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Roche & Novartis
  6.3.2 Asthma Drugs Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Roche & Novartis Asthma Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Teva
  6.4.2 Asthma Drugs Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Teva Asthma Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Merck
  6.5.2 Asthma Drugs Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Merck Asthma Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 AstraZeneca
  6.6.2 Asthma Drugs Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 AstraZeneca Asthma Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Boehringer Ingelheim
  6.7.2 Asthma Drugs Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Boehringer Ingelheim Asthma Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview

7 ASTHMA DRUGS MANUFACTURING COST ANALYSIS

7.1 Asthma Drugs Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Asthma Drugs

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Asthma Drugs Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Asthma Drugs Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES ASTHMA DRUGS MARKET SIZE (VALUE AND VOLUME) FORECAST (2017-2022)

11.1 United States Asthma Drugs Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Asthma Drugs Sales Volume Forecast by Type (2017-2022)
11.3 United States Asthma Drugs Sales Volume Forecast by Application (2017-2022)
11.4 United States Asthma Drugs Sales Volume Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Asthma Drugs
Figure United States Asthma Drugs Market Size (K Units) by Type (2012-2022)
Figure United States Asthma Drugs Sales Volume Market Share by Type (Product Category) in 2016
Figure Long-term Control Medications Product Picture
Figure Quick-relief Medications (Rescue Medications) Product Picture
Figure Medications for Allergy-induced Asthma Product Picture
Figure United States Asthma Drugs Market Size (K Units) by Application (2012-2022)
Figure United States Sales Market Share of Asthma Drugs by Application in 2016
Figure Hospital Pharmacy Examples
Table Key Downstream Customer in Hospital Pharmacy
Figure Retail Pharmacy Examples
Table Key Downstream Customer in Retail Pharmacy
Figure Online Pharmacy Examples
Table Key Downstream Customer in Online Pharmacy
Figure United States Asthma Drugs Market Size (Million USD) by Region (2012-2022)
Figure The West Asthma Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Asthma Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Asthma Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Asthma Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Asthma Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Asthma Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Asthma Drugs Sales (K Units) and Growth Rate (2012-2022)
Figure United States Asthma Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Asthma Drugs Market Major Players Product Sales Volume (K Units) (2012-2017)
Table United States Asthma Drugs Sales (K Units) of Key Players/Suppliers (2012-2017)
Table United States Asthma Drugs Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Asthma Drugs Sales Share by Players/Suppliers
Figure 2017 United States Asthma Drugs Sales Share by Players/Suppliers
Figure United States Asthma Drugs Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Asthma Drugs Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Asthma Drugs Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Asthma Drugs Revenue Share by Players/Suppliers
Figure 2017 United States Asthma Drugs Revenue Share by Players/Suppliers
Table United States Market Asthma Drugs Average Price (USD/Unit) of Key Players/Suppliers (2012-2017)
Figure United States Market Asthma Drugs Average Price (USD/Unit) of Key Players/Suppliers in 2016
Figure United States Asthma Drugs Market Share of Top 3 Players/Suppliers
Figure United States Asthma Drugs Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Asthma Drugs Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Asthma Drugs Product Category
Table United States Asthma Drugs Sales (K Units) by Region (2012-2017)
Table United States Asthma Drugs Sales Share by Region (2012-2017)
Figure United States Asthma Drugs Sales Share by Region (2012-2017)
Figure United States Asthma Drugs Sales Market Share by Region in 2016
Table United States Asthma Drugs Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Asthma Drugs Revenue Share by Region (2012-2017)
Figure United States Asthma Drugs Revenue Market Share by Region (2012-2017)
Figure United States Asthma Drugs Revenue Market Share by Region in 2016
Table United States Asthma Drugs Price (USD/Unit) by Region (2012-2017)
Table United States Asthma Drugs Sales (K Units) by Type (2012-2017)
Table United States Asthma Drugs Sales Share by Type (2012-2017)
Figure United States Asthma Drugs Sales Share by Type (2012-2017)
Figure United States Asthma Drugs Sales Market Share by Type in 2016
Table United States Asthma Drugs Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Asthma Drugs Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Asthma Drugs by Type (2012-2017)
Figure Revenue Market Share of Asthma Drugs by Type in 2016
Table United States Asthma Drugs Price (USD/Unit) by Types (2012-2017)
Figure United States Asthma Drugs Sales Growth Rate by Type (2012-2017)
Table United States Asthma Drugs Sales (K Units) by Application (2012-2017)
Table United States Asthma Drugs Sales Market Share by Application (2012-2017)
Figure United States Asthma Drugs Sales Market Share by Application (2012-2017)
Figure United States Asthma Drugs Sales Market Share by Application in 2016
Table United States Asthma Drugs Sales Growth Rate by Application (2012-2017)
Figure United States Asthma Drugs Sales Growth Rate by Application (2012-2017)
Table GlaxoSmithKline Basic Information List
Table GlaxoSmithKline Asthma Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure GlaxoSmithKline Asthma Drugs Sales Growth Rate (2012-2017)
Figure GlaxoSmithKline Asthma Drugs Sales Market Share in United States (2012-2017)
Figure GlaxoSmithKline Asthma Drugs Revenue Market Share in United States (2012-2017)
Table Sanofi Basic Information List
Table Sanofi Asthma Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Sanofi Asthma Drugs Sales Growth Rate (2012-2017)
Figure Sanofi Asthma Drugs Sales Market Share in United States (2012-2017)
Figure Sanofi Asthma Drugs Revenue Market Share in United States (2012-2017)
Table Roche & Novartis Basic Information List
Table Roche & Novartis Asthma Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Roche & Novartis Asthma Drugs Sales Growth Rate (2012-2017)
Figure Roche & Novartis Asthma Drugs Sales Market Share in United States (2012-2017)
Figure Roche & Novartis Asthma Drugs Revenue Market Share in United States (2012-2017)
Table Teva Basic Information List
Table Teva Asthma Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Teva Asthma Drugs Sales Growth Rate (2012-2017)
Figure Teva Asthma Drugs Sales Market Share in United States (2012-2017)
Figure Teva Asthma Drugs Revenue Market Share in United States (2012-2017)
Table Merck Basic Information List
Table Merck Asthma Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Merck Asthma Drugs Sales Growth Rate (2012-2017)
Figure Merck Asthma Drugs Sales Market Share in United States (2012-2017)
Figure Merck Asthma Drugs Revenue Market Share in United States (2012-2017)
Table AstraZeneca Basic Information List
Table AstraZeneca Asthma Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure AstraZeneca Asthma Drugs Sales Growth Rate (2012-2017)
Figure AstraZeneca Asthma Drugs Sales Market Share in United States (2012-2017)
Figure AstraZeneca Asthma Drugs Revenue Market Share in United States (2012-2017)
Table Boehringer Ingelheim Basic Information List
Table Boehringer Ingelheim Asthma Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Boehringer Ingelheim Asthma Drugs Sales Growth Rate (2012-2017)
Figure Boehringer Ingelheim Asthma Drugs Sales Market Share in United States (2012-2017)
Figure Boehringer Ingelheim Asthma Drugs Revenue Market Share in United States (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Asthma Drugs
Figure Manufacturing Process Analysis of Asthma Drugs
Figure Asthma Drugs Industrial Chain Analysis
Table Raw Materials Sources of Asthma Drugs Major Players/Suppliers in 2016
Table Major Buyers of Asthma Drugs
Table Distributors/Traders List
Figure United States Asthma Drugs Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure United States Asthma Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Asthma Drugs Price (USD/Unit) Trend Forecast (2017-2022)
Table United States Asthma Drugs Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Asthma Drugs Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Asthma Drugs Sales Volume (K Units) Forecast by Type in 2022
Table United States Asthma Drugs Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Asthma Drugs Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Asthma Drugs Sales Volume (K Units) Forecast by Application in 2022
Table United States Asthma Drugs Sales Volume (K Units) Forecast by Region (2017-2022)
Table United States Asthma Drugs Sales Volume Share Forecast by Region (2017-2022)
Figure United States Asthma Drugs Sales Volume Share Forecast by Region (2017-2022)
Figure United States Asthma Drugs Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources